Histogenics Corporation Acquires ProChon Biotech Ltd.

WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a privately held regenerative medicine company, announced today that it has acquired ProChon Biotech, Ltd. in a stock-for-stock exchange.

MORE ON THIS TOPIC